Mayinglong Pharmaceutical Group Co., Ltd.

Mayinglong Pharmaceutical Group Co., Ltd.

600993.SS
Mayinglong Pharmaceutical Group Co., Ltd.CN flagShanghai Stock Exchange
23.27
CNY
+0.47
- -
10.03BMarket Cap

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) Stock Split History

Learn about Mayinglong Pharmaceutical Group Co., Ltd.'s most recent 13-for-10 basis stock split on July 21, 2015. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Mayinglong Pharmaceutical Group Co., Ltd.'s most recent stock split

Split Date: 2015-07-21
Split Ratio: 13:10
Price Before Split: $34.71
Price After Split: $26.70

Developer API

Get 600993.SS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/600993.SS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.30 times more shares (a 13:10 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Mayinglong Pharmaceutical Group Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2015-07-2113:10No$34.71$26.70
2011-05-202:1No$40.35$20.18
2009-06-129:5No$40.76$22.65
2008-06-043:2No$41.35$27.57
2007-05-316:5No$75.82$63.18
2006-07-186:5No$34.27$28.56

About Mayinglong Pharmaceutical Group Co., Ltd.

Company overview and industry information

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 13-for-10 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Mayinglong Pharmaceutical Group Co., Ltd. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.